ANNOUNCEMENT


13th International Conference on BioMedical Engineering
(ICBME08)
3rd - 6th December 2008, Singapore

www.icbme.org

Jointly Organised by:
National University of Singapore (Yong Loo Lin School of
Medicine & Faculty of Engineering) & Biomedical Engineering Society
(Singapore)

The 13th International Conference on Biomedical
Engineering (ICBME2008) will be held from the 3rd to 6th December 2008
in Singapore. The ICBME is a series of biennial international conference
in biomedical engineering held in Singapore. Our past conferences have
been successful in attracting about 800 participants from more than 30
countries. We would like to invite you to submit your abstracts in the
following topic areas. Topic area inludes but are not limited to:

* Artificial Organs
* Bioengineering Education
* Bioinformatics & Digital Medicine
* Biomaterials
* Biomechanics
* Biomedical Imaging
* Biomedical Instrumentation
* Biosensors, BioMEMs & Lab-on-Chip
* Biosignal Processing
* Cardiovascular Bioengineering
* Cell & Biomolecular Mechanics
* Cellular & Biomolecular Engineering
* Clinical Engineering
* Computational Bioengineering
* Computer-Integrated & Computer-Assisted Surgery
* Controlled Drug Delivery
* Mechanobiology
* Medical Robotics
* Micro Nano Biomedical devices & systems
* Nanobiotechnology
* Neural Systems Engineering
* Orthopaedics, Prosthetics & Orthotics
* Rehabilitation Engineering & Assistive Technology
* Pharmaceutical Sciences & Engineering
* Physiological System Modeling
* Regenerative Medicine & Tissue Engineering
* Telemedicine & Healthcare

*Closing date for Abstracts submission: 30th
July 2008
*Notification of acceptance: 30th Aug
2008
*Closing date for submission of full papers: 30th Sep 2008

We welcome your participation.

James Goh :: Chairman, 13th International Conference on Biomedical
Engineering:: Jointly organised by National University of Singapore &
Biomedical Engineering Society (Singapore) :: 65-6516 5259(DID) ::
65-6776 5322(Fax) :: dosgohj@nus.edu.sg (E) :: www.icbme.org (W)
Important: This email is confidential and may be privileged. If you are
not the intended recipient, please delete it and notify us immediately;
you should not copy or use it for any purpose, nor disclose its contents
to any other person. Thank you.